---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-018540"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:43:35.229691+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Reviva announces $3M registered direct offering of 1.9M shares and warrants at $1.58/unit

## Summary
- Sold 1,898,734 shares and warrants at $1.58/unit; warrants exercisable at $1.455 for 5 years.
- Net proceeds ~$3.0M; funds Phase 3 RECOVER-2 trial and working capital.
- Existing Nov 2023 warrants (1,365,854 shares, $5.00 exercise) amended to $1.455, extended 5 years.
- H.C. Wainwright placement agent; cash fee 6% of gross proceeds.
- Closing expected May 29, 2024, subject to customary conditions.

## SEC filing metadata
- accession: 0001437749-24-018540
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774924018540/0001437749-24-018540-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774924018540/rvph20240528_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-018540
- JSON: https://secwatch.observer/filing/0001437749-24-018540.json
- Plain text: https://secwatch.observer/filing/0001437749-24-018540.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.